세계의 신경 과학 시장 보고서(2025년)
Neuroscience Global Market Report 2025
상품코드 : 1821649
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,444,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,314,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,184,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신경 과학 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에 CAGR은 7.6%를 나타낼 것으로 예측되고 502억 7,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 신경학적 치료 분야의 정밀의학, 신경약리학의 확장, 빅데이터 관리를 위한 신경정보학, 신경학적 치료에서의 환자 중심 접근법, 신경계 질환에 대한 전 세계 보건 이니셔티브, 신경학적 진단 분야의 혁신, 윤리적 고려사항 및 가이드라인 등에 기인할 수 있습니다. 주요 동향으로는 뇌 영상 기술, 신경자극 치료, 신경과학 분야 인공지능, 뇌-컴퓨터 인터페이스(BCI) 기술, 신경학 원격의료, 산업계와 학계의 협력, 학제간 접근법 등이 있습니다.

향후 5년간 7.6% 성장 전망은 이전 예측 대비 0.1% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 장벽은 독일과 일본에서 원하는 심부 뇌 자극(DBS) 장치의 비용을 증가시켜 운동 장애 치료 지연과 신경과 부서 지출 증가로 이어질 것으로 예상됩니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더 광범위하게 될 것입니다.

노인 인구 증가가 신경과학 시장을 견인할 것으로 전망됩니다. 65세 이상 인구는 노인 인구로 분류됩니다. 면역력 감축과 고령화로 인해 이 집단은 신경계 질환을 포함한 다양한 질병에 더 취약합니다. 노년층에 흔히 발생하는 신경계 질환으로는 요추 관절증과 치매가 있으며, 둘 다 신경과학을 통해 치료가 가능합니다. 예를 들어, 미국에 기반을 둔 외교·정치 국제기구인 유엔(UN)의 2022년 7월 보고서에 따르면, 전 세계 65세 이상 인구는 2022년 10%에서 2050년까지 16%로 증가할 것으로 전망되어, 세기 중반까지 전 세계적으로 이 연령층이 상당한 증가를 보일 것임을 시사합니다. 따라서 증가하는 노인 인구는 신경과학 시장의 주요 촉진요인입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Neuroscience, delving into the intricacies of the human nervous system and brain, integrates cellular and molecular biology, anatomy, physiology, human behavior, cognition, and related fields to comprehensively map brain functionalities. Its applications extend to the development of pharmaceuticals, treatments, and preventive methodologies for various health conditions, offering solutions to a spectrum of health concerns.

Diverse branches within neuroscience encompass neuro-microscopy, electrophysiology technologies, neuro-cellular manipulation, whole brain imaging, and other specialized tools provided through instruments, consumables, software, and services. Neuro-microscopy, tailored for surgeries involving the brain, spinal cord, and spine, serves as an operating microscope. It facilitates illumination and magnification of deeper surgical fields, equipped with features like a binocular head with adjustable eyepieces and foot controls, ensuring enhanced precision and maneuverability. The application of neuroscience spans across hospitals, diagnostic labs, research facilities, and academic institutes, supporting various scientific endeavors and medical advancements.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The neuroscience market research report is one of a series of new reports from The Business Research Company that provides neuroscience market statistics, including neuroscience industry global market size, regional shares, competitors with a neuroscience market share, detailed neuroscience market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience industry. This neuroscience market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroscience market size has grown strongly in recent years. It will grow from $35.51 billion in 2024 to $37.47 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increased funding for neuroscience research, emergence of neuroinformatic, genomic and proteomic research in neuroscience, public awareness and education, drug discovery and development, global aging population, neuroscience-based education and learning.

The neuroscience market size is expected to see strong growth in the next few years. It will grow to $50.27 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to precision medicine in neurological treatments, expansion of neuropharmacology, neuroinformatic for big data management, patient-centric approaches in neurological care, global health initiatives for neurological disorders, innovations in neurological diagnostics, ethical considerations, and guidelines. Major trends in the forecast period include brain imaging technologies, neurostimulation therapies, artificial intelligence in neuroscience, brain-computer interface (BCI) technology, telemedicine in neurology, collaboration between industry and academia, cross-disciplinary approaches.

The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of deep brain stimulation (DBS) devices sourced from Germany and Japan, thereby delaying treatment for movement disorders and elevating neurology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing geriatric population is expected to boost the neuroscience market. Individuals aged 65 years and older are classified as part of the geriatric population. Due to reduced immunity and advancing age, this group is more vulnerable to various diseases, including neurological disorders. Common neurological conditions affecting older adults include lumbar arthrosis and dementia, both of which can be addressed through neuroscience. For example, a report by the United Nations, a US-based diplomatic and political international organization, stated in July 2022 that the global population aged 65 and older is projected to rise from 10% in 2022 to 16% by 2050, indicating a significant increase in this age group worldwide by mid-century. Therefore, the growing geriatric population is a key driver of the neuroscience market.

The rising incidence of neurological disorders, particularly Alzheimer's disease, is expected to drive growth in the neuroscience market. Neurological disorders encompass a wide range of medical conditions that primarily impact the nervous system, including the brain, spinal cord, and peripheral nerves. Alzheimer's disease is a progressive neurodegenerative disorder that significantly affects cognitive function and memory. Neuroscience plays a crucial role in understanding and treating Alzheimer's disease; by examining the structure and function of the nervous system, neuroscientists are uncovering the underlying causes of AD and developing new approaches for diagnosis, prevention, and treatment. For instance, a report by the Alzheimer's Association, a U.S.-based nonprofit organization focused on Alzheimer's care, support, and research, revealed in May 2024 that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising incidence of neurological disorders, such as Alzheimer's disease, is a significant driver of the neuroscience market.

Technological advancement is a significant trend gaining traction in the neuroscience market. Leading companies are focusing on developing innovative technologies such as artificial intelligence (AI) and machine learning to enhance neuroscience. AI allows machines to replicate and even exceed human cognitive abilities, with machine learning being a subset of AI. AI models are designed to perform intelligence-driven tasks, offering new insights into how similar processes are regulated within the brain. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology firm, partnered with Synthetic MR, a Sweden-based MRI software company, to launch Smart Quant Neuro 3D. This groundbreaking tool is designed for diagnosing and assessing brain disorders such as multiple sclerosis, traumatic brain injury, and dementia. The solution combines Philips' AI-powered SmartSpeed technology, the 3D SyntAc application, and Synthetic MR's SyMRI NEURO 3D software, providing healthcare providers with enhanced diagnostic capabilities to improve confidence and patient outcomes. Philips has exclusive rights to offer SyMRI NEURO 3D on its MR scanners.

Major companies operating in the neuroscience sector are concentrating on launching innovative products, such as brain implant technology, to maintain their competitive edge in the market. Brain implant technology involves devices that are directly inserted into the brain to interact with neural tissue, facilitating the stimulation, monitoring, or modulation of brain activity. For example, in October 2022, Axoft, a health technology company based in the U.S., introduced a groundbreaking brain implant technology designed for the treatment of long-term neurological disorders, which received FDA Breakthrough Device Designation. Their innovative gliosis-free implants can safely remain in the central nervous system over the long term, providing electrical stability and an ultra-high density of sensors for improved brain-electronics communication. Axoft's minimally invasive implants offer high-bandwidth, stable single-neuron measurements and can adapt to changes in the brain, ensuring long-term functionality without the need for frequent replacements, making them particularly suitable for brain-machine interfaces (BMI).

In March 2022, AbbVie, a biopharmaceutical company based in the United States, completed the acquisition of Syndesi Therapeutics SA for an undisclosed sum. AbbVie's objective behind this acquisition was to bolster its neuroscience portfolio by gaining access to Syndesi's range of advanced SV2A modulators, notably their flagship drug SDI-118. Syndesi Therapeutics SA, headquartered in Belgium, specializes in drug discovery within the field of neurology within the biotechnology sector.

Major companies operating in the neuroscience market are Alpha Omega Inc., General Electric Company, Siemens Healthineers AG, NeuroNexus Technologies Inc., Doric Lenses Inc., Blackrock Neurotech, Axion Biosystems Inc., Femtonics Ltd., Carl Zeiss AG, Danaher Corporation (Leica Microsystems), Koninklijke Philips N.V., Toshiba Corporation, Hitachi Medical Corporation, Scientifica Ltd., Intan Technologies Inc., Laserglow Technologies Inc., Mightex Systems, Neuralink Corporation, Kernel Corporation, BrainCo Inc., MindMaze Inc., Paradromics Inc., NeuroPro Inc., NeuroSky Inc., EMOTIV Inc., Cercare Medical A/S, Plexon Inc., Noldus Information Technology bv, Neuralynx Inc., Vigil Neuroscience

North America was the largest region in the neuroscience market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroscience market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuroscience market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroscience market consists of the revenues earned by consulting services, installation services, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroscience Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroscience market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neuroscience ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroscience market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Neuroscience Market Characteristics

3. Neuroscience Market Trends And Strategies

4. Neuroscience Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neuroscience Growth Analysis And Strategic Analysis Framework

6. Neuroscience Market Segmentation

7. Neuroscience Market Regional And Country Analysis

8. Asia-Pacific Neuroscience Market

9. China Neuroscience Market

10. India Neuroscience Market

11. Japan Neuroscience Market

12. Australia Neuroscience Market

13. Indonesia Neuroscience Market

14. South Korea Neuroscience Market

15. Western Europe Neuroscience Market

16. UK Neuroscience Market

17. Germany Neuroscience Market

18. France Neuroscience Market

19. Italy Neuroscience Market

20. Spain Neuroscience Market

21. Eastern Europe Neuroscience Market

22. Russia Neuroscience Market

23. North America Neuroscience Market

24. USA Neuroscience Market

25. Canada Neuroscience Market

26. South America Neuroscience Market

27. Brazil Neuroscience Market

28. Middle East Neuroscience Market

29. Africa Neuroscience Market

30. Neuroscience Market Competitive Landscape And Company Profiles

31. Neuroscience Market Other Major And Innovative Companies

32. Global Neuroscience Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroscience Market

34. Recent Developments In The Neuroscience Market

35. Neuroscience Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기